Anti-mitogenic and apoptotic effects of 5-HT1B receptor antagonist on HT29 colorectal cancer cell line

被引:33
|
作者
Ataee, Ramin [2 ,4 ]
Ajdary, Soheila [3 ]
Zarrindast, Mohammadreza [4 ]
Rezayat, Mehdi [4 ]
Hayatbakhsh, Mohammad Reza [1 ]
机构
[1] Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia
[2] Inst Pasteur, Dept Pharmacol & Biochem, Amol, Iran
[3] Inst Pasteur, Dept Immunol, Tehran, Iran
[4] Univ Tehran Med Sci, Dept Pharmacol, Tehran, Iran
关键词
Colon cancer; Serotonin; 5-HT receptor; Apoptosis; Protein expression; HUMAN COLON-CANCER; TRIPLE THERAPY; BREAST-CANCER; SEROTONINERGIC RECEPTOR; LUNG-CARCINOMA; TUMOR-GROWTH; IN-VITRO; GALANIN; OCTREOTIDE; 5-FLUOROURACIL/LEUKOVORIN;
D O I
10.1007/s00432-010-0801-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
There is lack of evidence about impact of 5-HT receptors on colorectal cancers. The current study was designed to investigate the role of serotonin and its receptors in colorectal cancer cell line and tissues. In cell cultures, we investigated the effects of 5-HT and 5-HT(1A,1B,1D) agonists and antagonists on proliferation of HT29 cells. We also tested apoptosis for the receptor antagonists. The expression of 5-HT1(A,B,D) receptor subtypes was examined by immunohistochemistry and western blotting. Our data indicated that 5-HT(1B) receptor was fully expressed in HT29 cell line and tumor tissues. MTT proliferation assay also revealed that serotonin and CP93129 dihydrochloride, a selective 5-HT(1B) receptor agonist, stimulated growth of HT29 cells. Further, SB224289 hydrochloride (that is a selective 5-HT(1B) receptor antagonist) had anti-proliferative and apoptotic effects on HT29 cells. The findings of this study provide evidence for the potential role of 5-HT(1B) receptor in colorectal cancer. Further investigation is required to explore the effect of receptor antagonists on the prevention, prognosis and treatment of patients with colorectal cancer.
引用
收藏
页码:1461 / 1469
页数:9
相关论文
共 50 条
  • [1] Anti-mitogenic and apoptotic effects of 5-HT1B receptor antagonist on HT29 colorectal cancer cell line
    Ramin Ataee
    Soheila Ajdary
    Mohammadreza Zarrindast
    Mehdi Rezayat
    Mohammad Reza Hayatbakhsh
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1461 - 1469
  • [2] Y25130 hydrochloride, a selective 5HT3 receptor antagonist has potent antimitogenic and apoptotic effect on HT29 colorectal cancer cell line
    Ataee, Ramin
    Ajdary, Soheila
    Zarrindast, Mohammadreza
    Rezayat, Mehdi
    Shokrgozar, Mohammad Ali
    Ataee, Amin
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2010, 19 (02) : 138 - 143
  • [3] Apoptotic effects of cisplatin on human colon cancer cell line (HT29)
    Gurbuz, Venhar
    Yilmaz, Akin
    Gokce, Ozlem
    Konac, Ece
    DRUG METABOLISM REVIEWS, 2010, 42 : 196 - 197
  • [4] The Apoptotic Effects of Cisplatin on Human Colon Cancer Cell Line (HT29)
    Gurbuz, Venhar
    Yilmaz, Akin
    Gokce, Ozlem
    Konac, Ece
    MARMARA MEDICAL JOURNAL, 2011, 24 (02): : 100 - 105
  • [5] Identification of a potent and selective 5-HT1B receptor antagonist
    Wyman, PA
    Marshall, HR
    Flynn, ST
    King, RJ
    Thompson, M
    Smith, PW
    Hadley, MS
    Price, GW
    Scott, CM
    Dawson, LA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (21) : 4708 - 4712
  • [6] Gamma-Tocopherol Enhances Apoptotic Effects of Lovastatin in Human Colorectal Carcinoma Cell Line (HT29)
    Rezaei, Mohsen
    Zeidooni, Leila
    Hashemitabar, Mahmoud
    Razzazzadeh, Sareh
    Mahdavinia, Masoud
    Ghasemi, Kosar
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2014, 66 (08): : 1386 - 1393
  • [7] Cell death in the colorectal cancer cell line HT29 in response to glucosinolate metabolites
    Lund, EK
    Smith, TK
    Clarke, RG
    Johnson, IT
    JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 2001, 81 (09) : 959 - 961
  • [8] The negative immunoregulatory effects of serotonin (5-HT) moduline, an endogenous 5-HT1B receptor antagonist with anti-anxiety properties
    Maes, M
    Kenis, G
    Bosmans, E
    CYTOKINE, 2002, 19 (06) : 308 - 311
  • [9] 5-HT1B and 5-HT2A receptor antagonist properties of SL 65.0472 in vivo
    O'Connor, SE
    Grosset, A
    Duval, N
    La Rochelle, CD
    Gautier, E
    Bidouard, JP
    Janiak, P
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 : U36 - U36
  • [10] Augmentation with a 5-HT1A but not a 5-HT1B receptor antagonist critically depends on the dose of citalopram
    Cremers, TIFH
    de Boer, P
    Liao, Y
    Bosker, FJ
    den Boer, JA
    Westerink, BHC
    Wikström, HV
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 397 (01) : 63 - 74